Open Government Portal
About this information
Open data is defined as structured data that is machine-readable, freely shared, used and built on without restrictions.
The key things to remember about open data are:
- #Availability and access#: the data must be available as a whole and at no more than a reasonable reproduction cost, preferably by downloading over the internet. The data must also be available in a convenient and modifiable form.
- #Re-use and redistribution#: the data must be provided under terms that permit re-use and redistribution including the intermixing with other datasets.
- #Universal participation#: everyone must be able to use, re-use and redistribute. There should be no discrimination against fields of endeavour or against persons or groups. For example, 'non-commercial' restrictions that would prevent 'commercial' use, or restrictions of use for certain purposes (e.g. only in education), are not allowed.
Information on risk management plan submissions for drugs including when to file, considerations, requirements, and compliance.
Opioid products need to include specific content within their RMP to address: the risk and uncertainties of opioid-related harms in …
Disclosure of the incremental value (42.86%) of the 100% GST and the federal portion of the HST rebate approved for …
The RMP summary should include specific sections, which mirror the EU RMP Summary format sections.
A Canadian-specific addendum should address: risks or uncertainties that are unique to the Canadian context, and measures that the manufacturer …
Each year, Health Canada receives thousands of reports of suspected adverse reactions (side effects) about drugs and natural health products …
To ensure that advertising material meets Canadian regulatory standards for advertisements for drugs and medical devices, advertising preclearance agencies (APAs) …
The following is a list of health product advisories, type I drug recalls and summaries of completed safety reviews published …
The following is a list of health product advisories, type I drug recalls and summaries of completed safety reviews published …
The following is a list of health product advisories, type I drug recalls and summaries of completed safety reviews published …